DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,401,588 | +9.6% | 9,680 | +6.1% | 0.09% | +6.0% |
| Q2 2023 | $2,192,139 | +78.0% | 9,124 | +86.9% | 0.08% | +66.0% |
| Q1 2023 | $1,231,798 | +12.6% | 4,882 | +18.5% | 0.05% | +2.0% |
| Q4 2022 | $1,094,308 | +0.0% | 4,119 | -2.7% | 0.05% | -16.9% |
| Q3 2022 | $1,094,000 | +3.4% | 4,233 | +1.5% | 0.06% | -9.2% |
| Q2 2022 | $1,058,000 | +45.9% | 4,170 | +68.9% | 0.06% | +10.2% |
| Q1 2022 | $725,000 | -9.6% | 2,469 | +1.3% | 0.06% | +13.5% |
| Q4 2021 | $802,000 | +15.2% | 2,437 | +6.7% | 0.05% | 0.0% |
| Q3 2021 | $696,000 | +49.0% | 2,283 | +31.4% | 0.05% | +26.8% |
| Q2 2021 | $467,000 | +29.0% | 1,737 | +8.1% | 0.04% | +5.1% |
| Q1 2021 | $362,000 | +11.4% | 1,607 | +9.8% | 0.04% | -4.9% |
| Q4 2020 | $325,000 | -41.5% | 1,463 | -38.7% | 0.04% | -62.0% |
| Q3 2020 | $556,000 | +110.6% | 2,385 | +59.9% | 0.11% | +120.4% |
| Q2 2020 | $264,000 | -1.9% | 1,492 | -68.8% | 0.05% | +6.5% |
| Q1 2018 | $269,000 | -23.8% | 4,787 | +33.4% | 0.05% | +2.2% |
| Q4 2017 | $353,000 | – | 3,588 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |